Purchase Order 75N95021P00488

Award Date 9/1/21
Potential Completion Date 4/30/22
Potential Value $1.1M
Funding Federal Agency
National Institute on Aging
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Boulder, CO 80301, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc., has been awarded a $552,500 firm fixed price purchase order by the National Institutes of Health National Institute on Aging to perform discovery-based proteomic assays on approximately 850 human plasma samples. The purpose is to identify molecular pathways that accelerate cognitive decline across stages of Alzheimer's disease, as requested in the solicitation titled "Predicting cognitive decline across the...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a firm-fixed-price purchase order valued at $26,000 to Somalogic Operating Co., Inc. doing business as CM Life Sciences II Inc. to perform discovery-based proteomic assays on approximately 40 human plasma samples. The work will be performed in Boulder, Colorado over a period of six months from August 2023 through March 2024. The purpose of the assays is to identify proteomic markers of...
This is a firm-fixed-price purchase order awarded by the National Institute on Aging, a civilian agency within the U.S. Department of Health and Human Services, to Somalogic Operating Co., Inc. doing business as CM Life Sciences II Inc. The $24,975.00 contract is for laboratory support services to deliver 7,000 protein measurements from plasma samples using Somalogic's proprietary SomaScan Discovery V4.1 platform. The services are to be performed at Somalogic's facility in Boulder, Colorado, and...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $566,800 firm fixed price purchase order to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc. The contract calls for the delivery of an aptamer-based proteomic assay to measure approximately 7,000 proteins in approximately 872 human plasma samples from the Nutrition for Precision Health cohort. The assay results will identify proteomic signatures that predict...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $28,000 purchase order contract to Somalogic Operating Co., Inc. doing business as CM Life Sciences II Inc. for whole-cell proteome analysis services. The contract is a firm fixed price order for proteome analysis to be performed at the contractor's Potomac, Maryland facility between August 9, 2023 and December 31, 2023 to support the NIH National Institute on Aging's research...
This firm-fixed-price purchase order was awarded by the National Institute on Aging (NIA), part of the U.S. Department of Health and Human Services, to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc. The $152,200.00 contract is for the purchase and installation of SomaScan 7K protein biomarker assay kits and reagents. This work supports ongoing and developing proteomics research projects within the NIA's Translational Gerontology Branch and other laboratories, including...
The National Institute on Aging, a civilian agency within the U.S. Department of Health and Human Services, awarded a $24,975.00 firm-fixed-price purchase order to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc. The contract is for laboratory testing services using Somalogic's proprietary SomaScan Discovery V4.1 platform, which can measure 7,000 protein biomarkers from plasma samples. This contract supports the agency's research initiatives and does not have a set-aside...
Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc., has been awarded a $25,000 purchase order contract by the National Institutes of Health's National Institute on Aging to provide laboratory testing services for SOMASCAN discovery. The testing services will support the NIH/NIA's biomedical research efforts over a one-year period of performance in Boulder, Colorado. As the prime contractor, CM Life Sciences II Inc. will leverage its proteomics platform to analyze...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $24,850 purchase order to Somalogic Operating Co., Inc. doing business as CM Life Sciences II Inc. to provide services needed for testing of patient samples. The firm fixed price contract runs from August 9, 2023 to December 8, 2023 and will be performed in Boulder, Colorado. No additional details were provided regarding subcontractors or the specific services requested. The award was made by...
This is a firm-fixed-price purchase order awarded by the National Institute on Aging (NIA), part of the Department of Health and Human Services, to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc. The $396,795.68 contract is for the delivery of 10 SomaScan 11K Assay V5.0 kits, which can measure up to 11,000 proteins using only 55 mL of human plasma. The kits must be compatible with the TECAN Fluent 780 automation system. This award is not associated with a set-aside...

This firm fixed-price purchase order valued at $1,098,000 was awarded by the National Institutes of Health National Institute on Aging to Somalogic Operating Co., Inc., doing business as CM Life Sciences II Inc. The contract calls for utilization of an aptamer-based proteomics platform to analyze approximately 1,800 archived plasma samples from the Baltimore Longitudinal Study of Aging. The purpose is to identify molecular pathways that accelerate pathological phosphorylation of tau, which is implicated in Alzheimer's disease. Specifically, the work will examine the relationship between baseline protein expression in the plasma samples and subsequent increases in tau levels, tau tangles, and cognitive decline. Performance will take place over a six-month period in Boulder, Colorado. There was no set-aside designation for this solicitation under NAICS code 621511 for medical laboratories.

Generated 12/29/23, 3:52 PM